Clinical & safety data analysis
Signal detection and review over clinical and safety datasets.
- Adverse-event and safety signal review
- Structured review of patient narratives
- Human-in-the-loop triage
Analysis of clinical, safety and real-world data for teams under regulatory scrutiny — traceable results that withstand review.
Clinical and safety data are expensive, sensitive and reviewed line by line. A model that cannot explain itself is not an efficiency gain; it is a new validation burden.
The promise of AI in drug development is real, but it only survives contact with a regulator if every result can be reproduced and traced. Enthusiasm is not evidence.
Our view: in a regulated setting, explainability is not a feature you add at the end. Traceability has to be designed into the model, the data and the workflow from the first day.
Signal detection and review over clinical and safety datasets.
Analysis of RWD/RWE where provenance determines whether the result is usable.
Every output tied to its source records and the model decision behind it.
Evidence and documentation prepared for review.
We learn the endpoints, data sources and the standard the result must meet.
We fine-tune and wire the model into your EDC / LIMS and analysis workflows.
We test against known results, document rationale and prepare the evidence for review.
We will run a focused analysis on a sample of your own data and show the provenance behind each result — before you commit to anything.
[email protected]